ArticleHypertension research : official journal of the Japanese Society of Hypertension2024

The renin-angiotensin-aldosterone system inhibitor dilemma in COVID-19: balancing cardiovascular benefits and viral risks.

Takahiro Okumura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.